Clinical Bioanalysis Services

Expert bioanalysis solutions to progress your clinical research pipelines.

Optimised biomarker and bioanalytical solutions for pipeline development

Synexa Life Sciences is a global provider of biomarker and bioanalytical services, specialising in the development, validation, and delivery of a wide range of complex and custom-designed assays.

With over two decades of experience, our bioanalytical laboratory strives to be at the forefront of scientific innovation, housing the tools and expertise required for successful compound development and market release. Our services seamlessly integrate into your discovery, preclinical, and clinical phases, delivering accurate, reliable, and streamlined bioanalytical solutions for even the most complex programs.

Bioanalytical Laboratory Services

Immunogenicity Assessment

Assessing the immunogenicity of therapeutic drugs is particularly important when considering the significance of anti-drug antibodies (ADA) in clinical studies. Our customisable assay panels are developed through rigorous method development and validation to ensure regulatory and sponsor-specific requirements are met, whilst simultaneously providing provide useful, clinically relevant data to facilitate the progression of your therapeutic pipeline.

PD Assays

Our PD assays, renowned for their sensitivity and specificity, are custom-developed and validated by our expert scientists, in collaboration with your team and according to your requirements. Assays are compatible with sample material from an extensive array of matrices and therefore are suitable for large-scale, high-throughput clinical bioanalysis studies.

PK/TK Analysis

Synexa’s comprehensive Pharmacokinetic (PK)/Toxicokinetic (TK) bioanalytical services meticulously assess absorption, distribution, metabolism, excretion and kinetics of toxic substances. Our expertise ensures that customers receive crucial insights, optimising drug safety and efficacy for successful therapeutic development.

Biosimilar Development

Synexa’s specialised bioanalytical labs, deep regulatory expertise and technical proficiencies make us the ideal partner for biosimilar therapeutic development. We tailor our services to each project, encompassing bioequivalence studies, anti-drug antibody (ADA) assessments and more. With a history of successful collaborations in clinical bioanalysis, we work closely with customers to navigate the complexities of biosimilar development while meeting stringent timelines and regulatory standards.

Our Bioanalytical Platforms

Our technology platforms are robust, reliable and reputable in the clinical field and provide comprehensive and detailed data readouts for your application.